The Tax-Advantaged Investing in the Biotech Sector report is now available.
In this new sector overview report on biotechnology, MJ Hudson Allenbridge examines the key drivers, the biggest myths, and likely threats to the global biotech industry, as well as the way in which investments in this area have been made under the UK Government’s tax-advantaged investment schemes. The report looks at the future of biotech and suggests to potential investors which questions to ask when making an investment in this space, including the trade-offs between investing with specialist versus generalist managers.
Look out for more newsletters and reports in the months ahead for the latest on what investors and managers should expect.
Fill out the form below to download your copy of the report today.
Copyright © 2019. All rights reserved.